Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Suppression of tumor suppressors in prostate cancer: the emergence of a novel oncogenic pathway.

Cancer cell - 1 Nov 2007

Thompson Timothy C

Abstract excerpt

Elucidating oncogenic pathways in prostate cancer is an arduous task. In this issue of Cancer Cell, Yu and colleagues show that repression of Adrenergic Receptor Beta-2 gene expression by Enhancer of Zeste 2 results in acquisition of transforming activities. It is interesting that these activitie...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclic AMP
Share to Gene Expression Regulation, Neoplastic
Share to GTP Phosphohydrolases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oncogenes

Share to Prostatic Neoplasms

Share to Receptors, Adrenergic, beta-2

Share to Shelterin Complex

Share to Telomere-Binding Proteins

Source

Identifiers

PMID: 17996641
DOI: 10.1016/j.ccr.2007.10.025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17996641-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Suppression of tumor suppressors in prostate cancer: the emergence of a novel oncogenic pathway.PMID 17996641Read ↗

Overexpression of RACGAP1 by E2F1 Promotes Neuroendocrine Differentiation of Prostate Cancer by Stabilizing EZH2 ExpressionSemantic proximity Read ↗

Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate CancerSemantic proximity Read ↗

Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cellsSemantic proximity Read ↗

Polycomb Group Protein Enhancer of Zeste 2 Is an Oncogene That Promotes the Neoplastic Transformation of a Benign Prostatic Epithelial Cell LineSemantic proximity Read ↗

β-Catenin Is Required for Prostate Development and Cooperates with Pten Loss to Drive Invasive CarcinomaSemantic proximity Read ↗

G Proteins in Cancer: The Prostate Cancer ParadigmSemantic proximity Read ↗

Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progressionSemantic proximity Read ↗

Cell-autonomous GP130 activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironmentSemantic proximity Read ↗

Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells.Semantic proximity Read ↗

ETS2 function is required to maintain the transformed state of human prostate cancer cells.Semantic proximity Read ↗

ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling.Semantic proximity Read ↗

Cdc42 in oncogenic transformation, invasion, and tumorigenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.